Therefore, we hypothesized that the expression level of miR-29a-3p could be promoted by silencing PSMA3-AS1, thereby blocking the role of STAT3 in PRAD and delaying the development of PRAD. This evidence concerns the gene PSMA3 and prostate adenocarcinoma.